Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.

Government publications review (New York, N.Y. : 1982) Pub Date : 2016-09-06 eCollection Date: 2016-01-01 DOI:10.2147/IJN.S103344
Diogo Silva Pellosi, Francesca Moret, Aurore Fraix, Nino Marino, Sara Maiolino, Elisa Gaio, Noboru Hioka, Elena Reddi, Salvatore Sortino, Fabiana Quaglia
{"title":"Pluronic<sup>®</sup> P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells.","authors":"Diogo Silva Pellosi, Francesca Moret, Aurore Fraix, Nino Marino, Sara Maiolino, Elisa Gaio, Noboru Hioka, Elena Reddi, Salvatore Sortino, Fabiana Quaglia","doi":"10.2147/IJN.S103344","DOIUrl":null,"url":null,"abstract":"<p><p>Here, we developed Pluronic<sup>®</sup> P123/F127 (poloxamer) mixed micelles for the intravenous delivery of the anticancer drug sorafenib (SRB) or its combination with verteporfin (VP), a photosensitizer for photodynamic therapy that should complement well the cytotoxicity profile of the chemotherapeutic. SRB loading inside the core of micelles was governed by the drug:poloxamer weight ratio, while in the case of the SRB-VP combination, a mutual interference between the two drugs occurred and only specific ratios could ensure maximum loading efficiency. Coentrapment of SRB did not alter the photophysical properties of VP, confirming that SRB did not participate in any bimolecular process with the photosensitizer. Fluorescence resonance energy-transfer measurement of micelles in serum protein-containing cell-culture medium demonstrated the excellent stability of the system in physiologically relevant conditions. These results were in line with the results of the release study showing a release rate of both drugs in the presence of proteins slower than in phosphate buffer. SRB release was sustained, while VP remained substantially entrapped in the micelle core. Cytotoxicity studies in MDA-MB231 cells revealed that at 24 hours, SRB-loaded micelles were more active than free SRB only at very low SRB concentrations, while at 24+24 hours a prolonged cytotoxic effect of SRB-loaded micelles was observed, very likely mediated by the block in the S phase of the cell cycle. The combination of SRB with VP under light exposure was less cytotoxic than both the free combination and VP-loaded micelles + SRB-loaded micelles combination. This behavior was clearly explainable in terms of micelle uptake and intracellular localization. Besides the clear advantage of delivering SRB in poloxamer micelles, our results provide a clear example that each photochemotherapeutic combination needs detailed investigations on their particular interaction, and no generalization on enhanced cytotoxic effects should be derived a priori.</p>","PeriodicalId":81345,"journal":{"name":"Government publications review (New York, N.Y. : 1982)","volume":"16 1","pages":"4479-4494"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019320/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Government publications review (New York, N.Y. : 1982)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJN.S103344","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Here, we developed Pluronic® P123/F127 (poloxamer) mixed micelles for the intravenous delivery of the anticancer drug sorafenib (SRB) or its combination with verteporfin (VP), a photosensitizer for photodynamic therapy that should complement well the cytotoxicity profile of the chemotherapeutic. SRB loading inside the core of micelles was governed by the drug:poloxamer weight ratio, while in the case of the SRB-VP combination, a mutual interference between the two drugs occurred and only specific ratios could ensure maximum loading efficiency. Coentrapment of SRB did not alter the photophysical properties of VP, confirming that SRB did not participate in any bimolecular process with the photosensitizer. Fluorescence resonance energy-transfer measurement of micelles in serum protein-containing cell-culture medium demonstrated the excellent stability of the system in physiologically relevant conditions. These results were in line with the results of the release study showing a release rate of both drugs in the presence of proteins slower than in phosphate buffer. SRB release was sustained, while VP remained substantially entrapped in the micelle core. Cytotoxicity studies in MDA-MB231 cells revealed that at 24 hours, SRB-loaded micelles were more active than free SRB only at very low SRB concentrations, while at 24+24 hours a prolonged cytotoxic effect of SRB-loaded micelles was observed, very likely mediated by the block in the S phase of the cell cycle. The combination of SRB with VP under light exposure was less cytotoxic than both the free combination and VP-loaded micelles + SRB-loaded micelles combination. This behavior was clearly explainable in terms of micelle uptake and intracellular localization. Besides the clear advantage of delivering SRB in poloxamer micelles, our results provide a clear example that each photochemotherapeutic combination needs detailed investigations on their particular interaction, and no generalization on enhanced cytotoxic effects should be derived a priori.

Pluronic® P123/F127 混合胶束在癌细胞中递送索拉非尼及其与 verteporfin 的组合。
在这里,我们开发了Pluronic® P123/F127(poloxamer)混合胶束,用于静脉注射抗癌药物索拉非尼(SRB)或其与verteporfin(VP)的复方制剂,verteporfin是一种用于光动力疗法的光敏剂,可以很好地补充化疗药物的细胞毒性。SRB在胶束核心内的装载量受药物与聚氧乙烯醚重量比的影响,而在SRB-VP组合中,两种药物之间会发生相互干扰,只有特定的比例才能确保最大的装载效率。SRB 的共载不会改变 VP 的光物理特性,这证明 SRB 没有参与光敏剂的任何双分子过程。在含血清蛋白的细胞培养基中对胶束进行的荧光共振能量转移测量表明,该系统在生理相关条件下具有出色的稳定性。这些结果与释放研究的结果一致,即两种药物在蛋白质存在下的释放速度都比在磷酸盐缓冲液中慢。SRB 的释放是持续性的,而 VP 则被大量裹挟在胶束核心中。在 MDA-MB231 细胞中进行的细胞毒性研究表明,在 24 小时内,只有在 SRB 浓度非常低的情况下,SRB 加载胶束才比游离 SRB 更有活性,而在 24+24 小时内,SRB 加载胶束的细胞毒性作用被延长,这很可能是由细胞周期 S 期的阻滞介导的。在光照下,SRB 与 VP 的组合比游离组合和负载 VP 的胶束+SRB-负载胶束组合的细胞毒性都要小。从胶束吸收和细胞内定位的角度可以清楚地解释这种行为。除了在聚氧乙烯胶束中递送 SRB 的明显优势外,我们的研究结果还提供了一个明显的例子,即每种光化学治疗组合都需要对其特定的相互作用进行详细的研究,而不能先验地得出增强细胞毒性效应的结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信